Delivery Order SPE2DB22D1002-SPE2DB24FKYT5
- Not listed
- This federal contract award is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,904.95 firm fixed-price contract is for Advair HFA 115-21 MCG Inhaler 12GM, a respiratory medication. The contract has an ultimate completion date of January 22, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,258.23 firm-fixed-price delivery order is for the supply of Advair HFA 115-21 MCG Inhaler 12GM, a pharmaceutical product, with a completion date of November 14, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,122.46, is a delivery order for the supply of an Advair HFA 45-21 MCG Inhaler 12GM, a pharmaceutical product. The contract has a completion date of January 28, 2025 and is a firm fixed-price arrangement. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,806.05 Firm Fixed Price Delivery Order contract is for the supply of Advair HFA 45-21 MCG Inhaler 12GM, a pharmaceutical product. The contract has a period of performance through May 22, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the...
- This federal contract award was granted to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The $7,346.71 firm fixed-price delivery order is for the supply of Advair HFA 115-21 MCG Inhalers, with an ultimate completion date of April 18, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,197.86 firm-fixed-price delivery order is for the supply of 4,568,157,247 units of the prescription medication Advair HFA 45-21 MCG Inhaler, with a completion date of May 7, 2025. The award is not associated with any set-aside program and appears to be part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,661.61, is for the delivery of Advair HFA 45-21 MCG inhalers. It is a firm fixed-price delivery order contract with an ultimate completion date of April 15, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical,...
- This is a Delivery Order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,589.44 firm fixed-price contract is for the supply of the pharmaceutical product Advair HFA 230-21 MCG Inhaler 12GM. The contract has an ultimate completion date of July 25, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
- This federal contract award is a delivery order placed by the Defense Logistics Agency (DLA) with AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $4,270.22, is for the supply of Advair HFA 230-21 MCG Inhaler 12GM, a critical pharmaceutical product. The contract has an ultimate completion date of November 13, 2024 and is a firm fixed-price contract. This award is part of a larger Indefinite Delivery Contract (IDC) valued at...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,047.74 firm fixed-price delivery order is for the supply of Advair HFA 230-21 MCG Inhaler 12GM, a prescription medication used to treat respiratory conditions. The contract has an ultimate completion date of August 7, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- SPE2DB22D1002Indefinite Delivery Contract
- SPE2DB22D1002-SPE2DB24FKYT5Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,515.03 firm fixed-price delivery order is for the supply of Advair HFA 45-21 MCG Inhaler 12GM, a medical product used in respiratory care. The contract has an ultimate completion date of March 4, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract was not set aside for any specific business category.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 3/1/24 |